FARMABIOS SPA

Overview

FARMABIOS SPA is an active pharmaceutical ingredient (API) supplier with 55 active FDA Type II Drug Master Files, covering BECLOMETASONE DIPROPIONATE MONOHYDRATE MICRONIZED; BECLOMETHASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE MICRONIZED; BETAMETHASONE VALERATE; BUDESONIDE; BUDESONIDE MICRONIZED STERILE.

API / Drug Master Files

FARMABIOS SPA holds 55 active (57 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• DEXAMETHASONE MICRONIZED STERILEActive2026-03-25
• TRIAMCINOLONE HEXACETONIDE MICRONIZED STERILEActive2026-03-17
• TESTOSTERONE CYPIONATEActive2025-07-22
• PREDNISOLONEActive2024-10-31
• PREDNISOLONE SODIUM PHOSPHATEActive2024-10-30
• FLUTICASONE FUROATEActive2024-06-13
• HYDROCORTISONE HEMISUCCINATEActive2023-01-24
• FLUOROMETHOLONEActive2021-04-13
• CANNABIDIOLActive2019-07-24
• EPOXIDE DESOXYMETASONE (INTERMEDIATE)Active2019-06-26
• MOMETASONE FUROATE (ALTERNATE PROCESS)Active2019-03-11
• FORMOTEROL FUMARATEActive2018-07-27
• FULVESTRANTActive2018-07-27
• STERILE PREDNISOLONE-21-ACETATE MICRONIZEDActive2018-07-16
• DEXAMETHASONE USPActive2017-03-10

Showing 15 of 57 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to FARMABIOS SPA in our records. PharmaTek screens the full directory against live FDA enforcement data.